spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Meda AB 

 HSMN NewsFeed - 9 Jan 2017
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2016
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Jun 2016
GORE(R) VIABAHN(R) Endoprosthesis Found to Provide Superior Patency and Reduced Interventions Versus Balloon Angioplasty Alone for Challenging AV Access Cases
Devices Interventional
 HSMN NewsFeed - 10 Dec 2014
Gore Receives CE Mark Approval for GORE(R) VIABAHN(R) Endoprosthesis for Revision of Arteriovenous Access
Devices Regulatory
 HSMN NewsFeed - 7 Apr 2014
Meda and Valeant Terminates Joint Ventures
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2014
Statement by the Board of Directors of Meda
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Feb 2014
Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
Devices
 HSMN NewsFeed - 1 Oct 2013
CEO Change for Meda AB
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2013
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2013
EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2013
EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2012
New 10 cm GORE(R) Hybrid Vascular Graft Delivers Unprecedented Versatility
Devices Interventional
 HSMN NewsFeed - 8 Nov 2012
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 Sep 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Women's Health Business to Meda
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2012
EpiCept Regains Rights to Azixa(R) from Licensee Myrexis
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 23 Aug 2012
Actinium Pharmaceuticals Strengthens Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2012
Gore Receives CE Mark for GORE(R) Hybrid Vascular Graft
Devices Interventional Regulatory
 HSMN NewsFeed - 15 May 2012
New Executive Vice President Commercial Appointed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2012
MEDA: Maria Carell Appointed Regional Director for the US
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2011
Medivir Strengthens Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2011
GORE(R) Hybrid Vascular Graft Commercially Available in the United States
Devices
 HSMN NewsFeed - 7 Apr 2011
Meda to License Elidel to Valeant Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Mar 2011
Gore Reports First Patient Treated in the United States using GORE(R) VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System
Devices Interventional
 HSMN NewsFeed - 22 Feb 2011
Gore Receives CE Mark for GORE(R) PROPATEN(R) Vascular Graft for Hemodialysis Access
Devices Regulatory
 HSMN NewsFeed - 17 Feb 2011
Gore Announces FDA Approval of Next Evolution of GORE(R) VIABAHN(R) Endoprosthesis
Devices Interventional FDA
 HSMN NewsFeed - 23 Dec 2010
Mylan's Dey Pharma Partners with Meda to Market EpiPen(R) Auto-Injector in Europe
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 21 Dec 2010
EpiCept Announces Ceplene(R) Approved for Marketing in Israel
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Oct 2010
EpiCept Corporation and FDA Agree on Development Plan for Ceplene(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Oct 2010
Meda: European Approval for Breakyl
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Aug 2010
Meda acquires Alaven, a US specialty pharma company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2010
Meda: Ezogabine Receives Positive Vote From FDA Advisory Committee
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Jul 2010
EpiCept Corporation Names Rita Kelley Senior Director of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2010
EpiCept Corporation Announces Commercial Launch of Ceplene(R) in Germany
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 7 May 2010
Adeona Completes a $17.5 Million Corporate Partnership With Meda AB for the Development and Commercialization of Flupirtine for Fibromyalgia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 May 2010
Meda Acquires Exclusive Rights to flupirtine for fibromyalgia, a Potential USD Billion Indication
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Apr 2010
EpiCept Announces Commercial Launch of Ceplene(R) in the United Kingdom
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Feb 2010
Medivir partners with Meda to commercialize Xerese(TM) (Lipsovir(R)) in North America
Biopharmaceuticals
 HSMN NewsFeed - 11 Jan 2010
Meda In-Licenses Exclusive Rights To Ceplene
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Jan 2010
EpiCept Announces Commercial Licensing Agreement for Ceplene(R) with Meda in Europe and Pacific Rim
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Sep 2009
Meda: FDA Approval of the First Once-Daily Nasal Antihistamine
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2009
Meda: Onsolis receives FDA approval
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 16 Mar 2009
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jan 2009
Meda Acquires World-Wide Rights to Onsolis
Biopharmaceuticals Distribution
 HSMN NewsFeed - 5 Jan 2009
BioDelivery Sciences Closes $6 Million Transaction with Meda
Biopharmaceuticals Distribution
 HSMN NewsFeed - 12 Sep 2008
Meda: Acquisition of European Businesses from Valeant Completed
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Sep 2008
Valeant Pharmaceuticals Completes Sale of Certain European Operations to Meda AB
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Aug 2008
Meda Has Settled the U.S. Astelin Patent Litigation with Cobalt
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Aug 2008
Meda Acquires Product Portfolio from Roche
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Aug 2008
Meda Enters into Joint Venture with Valeant
Biopharmaceuticals
 HSMN NewsFeed - 7 Aug 2008
Valeant Announces Agreement to Enter into Joint Venture with Meda
Biopharmaceuticals
 HSMN NewsFeed - 4 Aug 2008
Meda Acquires European Businesses from American Valeant and Enters the Russian Market
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Aug 2008
Valeant Sells Certain Business Operations in Europe for $392 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Apr 2008
Meda and Orexo in a Potential Billion SEK Deal
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Jan 2008
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Oct 2007
Meda Acquires Recip
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Oct 2007
Alpharma Appoints John J. Howarth as Vice President, Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2007
FDA Approves SOMA(R) (carisoprodol) 250 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
Biopharmaceuticals Oncology Pain Management
 HSMN NewsFeed - 20 Jul 2007
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2007
Meda Acquire Rights to the First Combination of an NSAID (Ketoprofen) and a Proton Pump Inhibitor (Omeprazole)
Biopharmaceuticals
 HSMN NewsFeed - 27 Apr 2007
Meda Acquires Product Portfolio from the US Pharma Company Wyeth
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Jan 2007
3M Completes Sale of its Pharmaceuticals Business in Europe
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Dec 2006
3M Completes Sale of its Pharmaceuticals Business in Asia Pacific Region
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Nov 2006
3M Reaches Agreements to Sell its Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 5 additional stories matching:
Meda AB
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.